Glenmark readies growth strategy for next 10 years

December 23, 2016Posted By Admin

Glenmark Pharmaceuticals, during its latest analyst meet, rolled out its ten year strategic roadmap for the company. This stresses innovation, complex generics and the specialty segment. Dermatology has been its core area of competence and it has named the oncology and respiratory segments as additional areas of focus.¬†Glenmark¬†believes about 30 per cent of its overall […]


Can Indian pharma companies beat the regulatory odds?

November 2, 2016Posted By Admin

Regulatory issues from US FDA(Food and Drug Administration) have created stir among pharma companies and have soured investor sentiment towards pharma stocks. But this is not the final and with its structural advantages India is going to play much bigger role in $1.2trillion global pharma market. Increase level of import alerts, export ban, warning letters […]


We are social 24/7 - Get in touch